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Related Literature 
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Question 
Characteristics of Patients 
Retrospective data analysis resulted variable timing of 
POC and serum testing (mean of 16 minutes between 
samples, SD of 8 min). This study would benefit from 
an interventional design with simultaneous 
measurements.
All intervention times were based on Epic records, 
which may not be entirely accurate or complete.
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Glucose monitoring a common invasive intervention 
in newborn period
•most commonly obtained laboratory value
Appropriate identification of hypoglycemia is 
critical:
•Severe hypoglycemia can lead to neurologic 
insult
•Cerebral palsy, developmental delay, seizures, 
death
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• Retrospective data analysis
INCLUDED: 
• all infants on the FM and Newborn services from 
July 1st, 2017 to June 30th, 2018.
• < 30 days old
• had both a POC and a serum measurement 
performed within 30 minutes of one another, 
and no documented feeding or administration of 
glucose in the intervening time
EXCLUDED: 
• Infants w/glucose of nutrition within 30 min of 
the first measurement with rising glucose value
Our POC meter appears to have poor 
sensitivity for hypoglycemia
Our meter appears to have clinically 
significant error, with a bias toward 
overestimation of glucose in hypoglycemic 
infants
Our meter does not appear to be meeting 
FDA or ISO guidelines in this population
POC glucometers are subject to error in 
situations very common in neonates: 
 Hypoxemia
 Poor perfusion
 Hyperbilirubinemia
 Abnormal hematocrit
 Acetaminophen administration
 Alcohol on the overlying skin
 Peripheral vasoconstriction
Current Recommendations vary:
ISO 2003 - 95% of values should fall:
• within +/- 15 mg/dl for glucose concentrations < 75 
mg/dl
ISO 2013 - 95% of values should fall: 
• within +/- 15 mg/dl for glucose concentrations < 100 
mg/dl 
FDA 2014 - 99% of all values should fall:
• within +/- 7 mg/dl for values < 70 mg/dl
Analysis of 17 different POC devices in 2017:
- 7 met ISO 2003 Criteria. 
- 2 met ISO 2013 criteria (Ekhlaspour et al, 2017). 
MMC uses FreeStyle Precision Pro meters, 
manufactured by Abbott 
-No independent validation trial
-manufacturer website states that they are ISO 
2013 compliant
-Not studied in neonates
Thank you to David Cox, MD; Brian Youth, MD; Timothy Hayes, MD, 
DVM for their assistance and support.
POC Sensitivity 
for BG <40: 
64.5% (± 16.4%)
POC Specificity 
for BG <40: 
52.6% (± 15.9%)
POC Glucometer performance relative to ISO Guidelines
Mean Serum – POC reflects degree of 
bias. All categories have significant error in 
measurement, but only in neonates with low serum 
measurements is that error biased toward
overestimation.
What is the accuracy of 
neonatal glucose measures 
at MMC?
RESULTS
Serum 
<40
Serum 
≥40
POC 
<40 20 18
POC 
≥40 11 92
N
Mean 
absolute 
difference 
(mg/dl)
Standard 
deviation 
of  
absolute 
difference 
(mg/dl)
Mean 
POC
Mean 
Serum
Mean Serum-
POC
Overall 141 10.23 12.14 54.93 53.74 -1.19
Serum <40 31 13.13 17.59 42.32 33.07 -9.25
Serum >40 110 9.42 10.06 58.48 59.43 0.95
Age in Days
0 66 9.82 9.69 53.38 54.11 0.73
1 52 11.4 15.86 55.90 53.00 2.90
2-3 19 8.74 9.19 56.53 52.11 -4.42
4+ 4 9.00 4.69 60.25 61.25 1.00
Weight
AGA 104 9.99 11.52 57.36 55.83 -1.53
SGA 19 8.42 6.59 49.32 49.42 0.10
LGA 18 13.56 18.67 46.83 45.38 -1.45
Infant of  
DM Mother 10 9.20 9.89 55.50 54.90 -0.60
Number of  samples
Number of  POC > 15 
mg/dl different than 
Serum
Overall 141 30 (21.28%)
Serum <40 31 9 (29.03%)
Age in Days
0 66 14 (21.21%)
1 52 12 (23.08%
2-3 19 3 (15.79%)
4+ 4 1 (25.00%)
Weight
AGA 104 22 (21.15%)
SGA 19 3 (15.79%)
LGA 18 6 (33.33%)
Table 1: Properties of  blood glucose samples by delivery type, age, and 
ICD10 codes (N=141)
Number of  infants %
Delivery Type
Vaginal 74 52.48%
C-section 65 46.10%
Transfer from outside hospital 2 1.42%
Age in days 
0 66 46.81%
1 52 36.88%
2-3 19 13.48%
4+ 4 2.84%
SGA 19 13.48%
LGA 18 12.77%
At risk for hypoglycemia 42 29.79%
DM in Mother 10 7.09%
Neonatal sepsis 0 0%
Hypoglycemia 19 13.48%
Neonatal seizure 0 0%
Neonatal abstinence 4 2.84%
Infants with multiple diagnosis codes 19 13.48%
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